Neonc Technologies Holdings (NTHI) Retained Earnings (2024 - 2026)
Neonc Technologies Holdings (NTHI) posted quarterly Retained Earnings of -$121.6 million for Q1 2026, down 46.59% year-over-year from -$227.6 million in Q1 2025, and down 7.82% quarter-over-quarter from -$112.8 million in Q4 2025.
Neonc Technologies Holdings (NTHI) Retained Earnings (2024 - 2026) Analysis & Trends
Neonc Technologies Holdings (NTHI) has reported Retained Earnings for 3 consecutive years, with -$121.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 46.59% year-over-year to -$121.6 million; the TTM figure through Mar 2026 stood at -$121.6 million (down 46.59% YoY), while the FY2025 annual figure was -$112.8 million, down 122.8% from the prior year.
- Retained Earnings slipped to -$121.6 million in Q1 2026 per NTHI's latest filing, from -$112.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$50.6 million in Q4 2024 and bottomed at -$121.6 million in Q1 2026.
- Historically, Retained Earnings has averaged -$92.3 million across 3 years, with a median of -$92.9 million in 2025.
- Annual changes were most pronounced in 2025 — Retained Earnings sank 122.8% — and 2026, when it tumbled 46.59%.
- Neonc Technologies Holdings' Retained Earnings stood at -$50.6 million in 2024, then tumbled by 122.8% to -$112.8 million in 2025, then declined by 7.82% to -$121.6 million in 2026.
- Business Quant data shows NTHI's Retained Earnings at -$121.6 million in Q1 2026, -$112.8 million in Q4 2025, and -$97.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.38 Bn |
| 10 | Neonc Technologies Holdings | 116.41 Mn | 116.41 Mn | - | -135.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -135.81 Mn |
| Mar 31, 2026 | -121.57 Mn |
| Dec 31, 2025 | -112.75 Mn |
| Sep 30, 2025 | -97.23 Mn |
| Jun 30, 2025 | -88.61 Mn |
| Mar 31, 2025 | -82.93 Mn |
| Dec 31, 2024 | -50.61 Mn |